Hutch News
Results per Page:
Targeted immunotherapy for deadly prostate cancer shows promise in preclinical test
Antibody-drug conjugate could be step toward selective treatment for neuroendocrine prostate cancer
Old and slow isn’t always the winning combo for critical genes
New work upends paradigm that young, rapidly evolving genes can’t be essential; highlights importance of 'junk' DNA
Cancer clinical trials: Creativity in the face of COVID-19
Faced with a global pandemic, scientists prioritize safety, patient benefit
Fruit flies add more weight to theory that individual bodies have set points
Researchers discover that a neural circuit responsible for sensing energy stores is designed to reset itself
Seeking targeted treatments for pancreatic cancer
American Cancer Society fellowship to Dr. Nithya Kartha supports search for vulnerabilities in most aggressive pancreatic tumor subtype
'Everything we’ve been training for is happening now'
How early-career virologists dropped everything to seize the opportunity, and face the challenges, of studying the coronavirus
Stalled science, missed mates and virtual everything
Torn between science and safety concerns, young scientists navigate a new normal as they try to launch their careers
New insights into drug resistance in small cell lung cancer
Scientists discover a single gene’s outsized role in drug resistance — and use its vulnerability to re-sensitize tumors to chemotherapy in preclinical models
Can a tumor that acts like a microbe help us develop better cancer therapies?
Understanding the genetics underlying spontaneous regression of an infectious tumor in Tasmanian devils could point us toward new treatment targets
Shifting liver cancer cells away from migratory state could reduce their drug resistance
Researchers hope lab-based study helps build foundation for personalized treatment of hepatocellular carcinoma
Dr. Rob Bradley named new McIlwain Family Endowed Chair in Data Science
Computational biologist uses data science to understand cancer biology and to seek new treatment targets
New study shows cancer-causing ‘Frankengene’ mutation could be target for new drugs
This gene is fused to many partner genes in different tumors. Now, scientists know it causes cancer — and how they might intervene
Antibodies a hot topic in COVID-19 research
Hutch scientists tap their antibody expertise for new tests, treatments, vaccines
Discovering new strategies used in arms race between bacteria and the viruses that infect them
Dr. Kevin Forsberg tapped for NIAID New Innovators Award to study arms race between viruses and bacteria
Studying how maternal immune factors shape infant health
Immunologist Dr. Megan Koch named 2020 Pew Scholar in the Biomedical Sciences
Mutated skin stem cells self-correct to prevent cancer
New study helps explain why inherited cancer-driving mutations don’t always lead to cancer
Pudgy middle age: Does a little fat have an upside?
Yeast studies of cellular aging suggest that middle-aged flab could help protect against stress
In cancer, the context 'makes' the mutation
Whether a mutated gene suppresses or promotes small-cell lung cancer depends on other mutations
Studying the complex interactions between antibodies and viral targets
Bloom Lab postdoc Dr. Tal Einav named Damon Runyon Quantitative Biology Fellow
Dr. Julie Overbaugh elected to American Academy of Arts & Sciences
Her HIV research revealed factors that influence HIV transmission